 PTAP Lowers the Cost of PoNS TherapyTM for Qualified Americans NEWTOWN, Pa., Jan. 05, 2023 GLOBE NEWSWIRE Helius Medical Technologies NASDAQ: HSDT today announced the extension of a program that puts the companys Portable Neuromodulation Stimulator PoNS into the hands of qualified Americans with multiple sclerosis MS at a significantly reduced cost. This initiative, ... The post Helius Extends its Patient Therapy Access Program PTAP, Bringing the Benefits of its PoNS Device to More... 